Vascular Dysfunction in Horses with Endocrinopathic Laminitis.

Endocrinopathic laminitis (EL) is a vascular condition of the equine hoof resulting in severe lameness with both welfare and economic implications. EL occurs in association with equine metabolic syndrome and equine Cushing's disease. Vascular dysfunction, most commonly due to endothelial dysfun...

Full description

Bibliographic Details
Main Authors: Ruth A Morgan, John A Keen, Brian R Walker, Patrick W F Hadoke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5042533?pdf=render
_version_ 1818029890888269824
author Ruth A Morgan
John A Keen
Brian R Walker
Patrick W F Hadoke
author_facet Ruth A Morgan
John A Keen
Brian R Walker
Patrick W F Hadoke
author_sort Ruth A Morgan
collection DOAJ
description Endocrinopathic laminitis (EL) is a vascular condition of the equine hoof resulting in severe lameness with both welfare and economic implications. EL occurs in association with equine metabolic syndrome and equine Cushing's disease. Vascular dysfunction, most commonly due to endothelial dysfunction, is associated with cardiovascular risk in people with metabolic syndrome and Cushing's syndrome. We tested the hypothesis that horses with EL have vascular, specifically endothelial, dysfunction. Healthy horses (n = 6) and horses with EL (n = 6) destined for euthanasia were recruited. We studied vessels from the hooves (laminar artery, laminar vein) and the facial skin (facial skin arteries) by small vessel wire myography. The response to vasoconstrictors phenylephrine (10-9-10-5M) and 5-hydroxytryptamine (5HT; 10-9-10-5M) and the vasodilator acetylcholine (10-9-10-5M) was determined. In comparison with healthy controls, acetylcholine-induced relaxation was dramatically reduced in all intact vessels from horses with EL (% relaxation of healthy laminar arteries 323.5 ± 94.1% v EL 90.8 ± 4.4%, P = 0.01, laminar veins 129.4 ± 14.8% v EL 71.2 ± 4.1%, P = 0.005 and facial skin arteries 182.0 ± 40.7% v EL 91.4 ± 4.5%, P = 0.01). In addition, contractile responses to phenylephrine and 5HT were increased in intact laminar veins from horses with EL compared with healthy horses; these differences were endothelium-independent. Sensitivity to phenylephrine was reduced in intact laminar arteries (P = 0.006) and veins (P = 0.009) from horses with EL. Horses with EL exhibit significant vascular dysfunction in laminar vessels and in facial skin arteries. The systemic nature of the abnormalities suggest this dysfunction is associated with the underlying endocrinopathy and not local changes to the hoof.
first_indexed 2024-12-10T05:26:53Z
format Article
id doaj.art-acee58e076394f6aa301a3e7f1d889db
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T05:26:53Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-acee58e076394f6aa301a3e7f1d889db2022-12-22T02:00:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016381510.1371/journal.pone.0163815Vascular Dysfunction in Horses with Endocrinopathic Laminitis.Ruth A MorganJohn A KeenBrian R WalkerPatrick W F HadokeEndocrinopathic laminitis (EL) is a vascular condition of the equine hoof resulting in severe lameness with both welfare and economic implications. EL occurs in association with equine metabolic syndrome and equine Cushing's disease. Vascular dysfunction, most commonly due to endothelial dysfunction, is associated with cardiovascular risk in people with metabolic syndrome and Cushing's syndrome. We tested the hypothesis that horses with EL have vascular, specifically endothelial, dysfunction. Healthy horses (n = 6) and horses with EL (n = 6) destined for euthanasia were recruited. We studied vessels from the hooves (laminar artery, laminar vein) and the facial skin (facial skin arteries) by small vessel wire myography. The response to vasoconstrictors phenylephrine (10-9-10-5M) and 5-hydroxytryptamine (5HT; 10-9-10-5M) and the vasodilator acetylcholine (10-9-10-5M) was determined. In comparison with healthy controls, acetylcholine-induced relaxation was dramatically reduced in all intact vessels from horses with EL (% relaxation of healthy laminar arteries 323.5 ± 94.1% v EL 90.8 ± 4.4%, P = 0.01, laminar veins 129.4 ± 14.8% v EL 71.2 ± 4.1%, P = 0.005 and facial skin arteries 182.0 ± 40.7% v EL 91.4 ± 4.5%, P = 0.01). In addition, contractile responses to phenylephrine and 5HT were increased in intact laminar veins from horses with EL compared with healthy horses; these differences were endothelium-independent. Sensitivity to phenylephrine was reduced in intact laminar arteries (P = 0.006) and veins (P = 0.009) from horses with EL. Horses with EL exhibit significant vascular dysfunction in laminar vessels and in facial skin arteries. The systemic nature of the abnormalities suggest this dysfunction is associated with the underlying endocrinopathy and not local changes to the hoof.http://europepmc.org/articles/PMC5042533?pdf=render
spellingShingle Ruth A Morgan
John A Keen
Brian R Walker
Patrick W F Hadoke
Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
PLoS ONE
title Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
title_full Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
title_fullStr Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
title_full_unstemmed Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
title_short Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
title_sort vascular dysfunction in horses with endocrinopathic laminitis
url http://europepmc.org/articles/PMC5042533?pdf=render
work_keys_str_mv AT ruthamorgan vasculardysfunctioninhorseswithendocrinopathiclaminitis
AT johnakeen vasculardysfunctioninhorseswithendocrinopathiclaminitis
AT brianrwalker vasculardysfunctioninhorseswithendocrinopathiclaminitis
AT patrickwfhadoke vasculardysfunctioninhorseswithendocrinopathiclaminitis